基本信息
浏览量:7
职业迁徙
个人简介
Research interests
Ron continues to practice as a renal pharmacist and has ongoing interest in a widerange of projects involving quality use of medicines in the hospital setting, and the provision of medication review services as patients are admitted to hospital from the community, and then discharged home again.
Ron's particular interest lies in promoting optimal use of medications in kidney disease.His collaborative work aims to support prescribers in choosing the best agent for individual patients, and then to facilitate patients achieving the best possible outcomes from their therapy. His ongoing projects include an exploration of adherence to medications among people with kidney disease, reporting of adverse drug reactions, factors influencing outcomes of peritonitis in peritoneal dialysis patients, clinical characteristics of patients with acute kidney injury, psychosocial issues affecting end-stage kidney disease patients and optimising the use of antimicrobials.
Ron's wide-rangingquality use of medicines projects have involved the usage of metformin in type 2 diabetes mellitus, medication use in patients with chronic kidney disease, early detection and prevention of chronic kidney disease, understanding determinants of medication adherence and current adherence assessment practices in Australian Haemodialysis patients, development of a prediction score for adverse drug reaction-related hospital admission, and medication appropriateness and regimen complexity in chronic kidney disease.
Ron has successfully supervised or co-supervisedpharmacy/nursing Honour’s students (9), Master of Pharmacy (2), and PhD candidates (7), to completion. These students have presented their research findings as paper and poster presentations at various national conferences, and in numerous publications in peer-reviewed journals.
Ron continues to practice as a renal pharmacist and has ongoing interest in a widerange of projects involving quality use of medicines in the hospital setting, and the provision of medication review services as patients are admitted to hospital from the community, and then discharged home again.
Ron's particular interest lies in promoting optimal use of medications in kidney disease.His collaborative work aims to support prescribers in choosing the best agent for individual patients, and then to facilitate patients achieving the best possible outcomes from their therapy. His ongoing projects include an exploration of adherence to medications among people with kidney disease, reporting of adverse drug reactions, factors influencing outcomes of peritonitis in peritoneal dialysis patients, clinical characteristics of patients with acute kidney injury, psychosocial issues affecting end-stage kidney disease patients and optimising the use of antimicrobials.
Ron's wide-rangingquality use of medicines projects have involved the usage of metformin in type 2 diabetes mellitus, medication use in patients with chronic kidney disease, early detection and prevention of chronic kidney disease, understanding determinants of medication adherence and current adherence assessment practices in Australian Haemodialysis patients, development of a prediction score for adverse drug reaction-related hospital admission, and medication appropriateness and regimen complexity in chronic kidney disease.
Ron has successfully supervised or co-supervisedpharmacy/nursing Honour’s students (9), Master of Pharmacy (2), and PhD candidates (7), to completion. These students have presented their research findings as paper and poster presentations at various national conferences, and in numerous publications in peer-reviewed journals.
研究兴趣
论文共 93 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ADVANCES IN KIDNEY DISEASE AND HEALTHno. 1 (2024): 68-83
Lipin Lukose,Gursimran Kaur, Mohammed M. Asif, Gail Ann Abraham,Kanav Khera,Viswam K. Subeesh,Ronald L. Castelino, Shubhada Karanth, Chandrashekar Udyavara Kudru,Muralidhar Varma,Sonal Sekhar Miraj
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2024)
KIDNEY INTERNATIONAL REPORTSno. 2 (2024): 277-286
MEDICAL JOURNAL OF AUSTRALIAno. 4 (2024): 184-185
JOURNAL OF CLINICAL MEDICINEno. 2 (2024): 343
THERAPEUTIC ADVANCES IN DRUG SAFETY (2024): 20420986241227014-20420986241227014
International journal of clinical pharmacyno. 4 (2023): 962-969
Seminars in dialysisno. 4 (2023): 273-277
BMJ OPENno. 12 (2023): e079110-e079110
Journal of nephrologyno. 7 (2023): 1841-1859
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn